Anaplastic Oligodendroglioma (AO) Completed Phase 1 / 2 Trials for Carboplatin (DB00958)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00303849Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsTreatment